Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,248
datasets available to search
ShareScore release 0.9.0
Dataset results
2,248 results for “squamous cell carcinoma”
Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04649476. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
ClinicalTrials.gov study NCT00865098. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02759575. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01198028. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01602315. IPD Sharing: NO. Countries: 9. Publications: 1.
Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)
ClinicalTrials.gov study NCT01437449. IPD Sharing: NO. Countries: 1. Publications: 1.
Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)
ClinicalTrials.gov study NCT02626000. IPD Sharing: YES. Countries: 11. Publications: 1.
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
ClinicalTrials.gov study NCT01133678. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03430843. IPD Sharing: YES. Countries: 11. Publications: 7.
Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment
ClinicalTrials.gov study NCT03116152. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base
ClinicalTrials.gov study NCT07145931. IPD Sharing: YES. Countries: 1. Publications: 15.
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02823574. IPD Sharing: Not stated. Countries: 21. Publications: 1.
Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00519077. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)
ClinicalTrials.gov study NCT05286619. IPD Sharing: YES. Countries: 1. Publications: 1.
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02521870. IPD Sharing: YES. Countries: 4. Publications: 1.
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
ClinicalTrials.gov study NCT03765918. IPD Sharing: YES. Countries: 24. Publications: 1.
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02296684. IPD Sharing: NO. Countries: 1. Publications: 1.
Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00084682. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03422536. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT03452137. IPD Sharing: Not stated. Countries: 23. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.